Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine

References

• Codes G, Fischer W, Legler U, Wolff HM. Proceedings of 3rd TTS symposium, Tokyo, 1987;3–8.
   Google Scholar
• Barry BW. Dermatological formulation. New York: Marcel Dekker Inc; 1983:225–238.
   Google Scholar
• Schaefer H, Zesch A, Stuttgen G. Skin permeability. New York: Springer Verlag; 1982:123–146.
   Google Scholar
• Santiago TM, Lopez LM. Nitrendipine, a new dihyropyridine calcium channel antagonist for treatment of hypertension. Drug Intell Clin Pharm Ann Pharmacother 1990;24(2):167–175.
   Google Scholar
• Goa LK, Sorkin EM. Nitrendipine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Drugs 1987;33:123–155.
   PubMed Web of Science ®Google Scholar
• Aronoff GR, Sloan RS. Nitrendipine kinetics in normal and impaired renal function. Clin Pharmacol Ther 1985;38(2):212–218.
   PubMed Web of Science ®Google Scholar
• Kann J, Krol GJ, Raemsch KD, Burkholder DE, Levitt MJ. Bioequivalence and metabolism of nitrendipine administered orally to healthy volunteers. J Cardiovasc Pharmacol 1984;6(suppl. 7):S969–972.
   PubMedGoogle Scholar
• Soons PA, Breimer DD. Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects. Br J Clin Pharmacol 1991;32:11–16.
   PubMed Web of Science ®Google Scholar
• Diez I, Colom H, Moreno J, Obach R, Peraire C, Domenech J. A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. J Pharm Sci 1991;80(10):931–934.
   PubMed Web of Science ®Google Scholar
• James E, Reynolds F. Nitrendipine. In: Martindale, The Extra Pharmacopoeia. 31st ed. Royal Pharmaceutical Society 1996:923.
   Google Scholar
• Laurent YG, Moffat AC, Osselton MD, Widdop B. Nitredipine. In:Clarke’s analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem. 3rd ed. Pharmaceutical Press: London, UK; 2004:1345.
   Google Scholar
• Ruan LP, Liang BW, Tao JZ, Yim CH. Transdermal absorption of nitrendipine from adhesive patches. J Control Rel 1992;20:231–236.
   Web of Science ®Google Scholar
• Dnyanesh NT, Pradeep RV. Acrylate-based transdermal therapeutic system of Nitrendipine. Drug Dev Ind Pharm 2003;29(1):71–78.
   PubMed Web of Science ®Google Scholar
• Ramesh G, Vamshi YV, KishanV, Madhusudan YR. Development of Nitrendipine transdermal patches: In vitro and ex-vivo characterization. Curr Drug Deliv 2007;4:69–76.
   PubMedGoogle Scholar
• Lanigan RS. Final report on the safety assessment of cocoyl sarcosine, lauroyl sarcosine, myristol sarcosine, oleoyl sarcosine, stearoyl sarcosine, sodium cocoyl sarcosinate, sodium lauroyl sarcosinate, sodium myristoyl sarcosinate, ammonium cocyl sarcosinate, and ammonium lauroyl sarcosinate. Int J Toxocol 2001;20:1–14
   PubMed Web of Science ®Google Scholar
• Chong KK, Jung JK, Sang CC, Chang KS. Effect of fatty acids and urea on the penetration of Ketoprofen through rat skin. Int J Pharm 1993;99:109–118.
   Google Scholar
• Giannakous A, Dallas PP, Rekkas DM, Choulis NH. Development and in vitro evaluation of nimodipine transdermal formulations using factorial design. Pharm Dev Technol 1998;3(4):517–525.
   PubMedGoogle Scholar
• Ruland A, Kreuter J. Influence of various penetration enhancers on the in vitro permeation of amino acids across hairless mouse skin. Int J Pharm 1992;85:7–17.
   Web of Science ®Google Scholar
• Mittal A, Sara UVS, Asgar A, Aqil M. The effect of penetration enhancers on permeation kinetics of Nitrendipine in two different skin models. Biol Pharm Bull 2008;31:1766–1772.
   PubMed Web of Science ®Google Scholar
• Pai RM, Desai MS, Babtiwale AD, Shrivastava R. Adhesive matrix type transdermal drug delivery system for nitroglycerin. Drug Dev Ind Pharm 1994;20:1905–1909.
   Web of Science ®Google Scholar
• Singh J, Tripathi KP, Sakia TR. Effect of penetration enhancers on the in vitro transport of ephedrine through rat skin and human epidermis from matrix based transdermal formulation. Drug Dev Ind Pharm 1993;19:1623–1628.
   Web of Science ®Google Scholar
• Mukherjee B, Das S, Das BP, Layek B. Nefopam containing transdermal matrix patches based on pressure sensitive adhesive polymers. Pharm Technol 2006;30:146–163.
   Google Scholar
• Guy R, Hadgraft J. Physicochemical interpretation of the pharmacokinetics of percutaneous absorbtion. J Pharma Biopharm 1983;11:189.
   PubMedGoogle Scholar
• Guy R, Hadgraft J. A pharmacokinetic model for percutaneous absorption. Int J Pharm 1982;11:119.
   Web of Science ®Google Scholar
• Guy R, Hadgraft J. Prediction of plasma levels of drugs following transdermal application. J Controlled Release 1985;1:177.
   Google Scholar
• Guy R, Hadgraft J. Pharmacokinetic interpretation of plasma levels of drug levels of clonidine following transdermal delivery. J Pharm Sci 1985;74:1016.
   PubMed Web of Science ®Google Scholar
• Guy R, Hadgraft J. Parameters of skin condition and function. In: Transdermal delivery of drugs. 3rd ed. Boca Raton, FL: CRC Press;1987:17.
   Google Scholar
• Aqil M, Sultana Y, Ali A, Dubey K, Nazmi Pillai KK. Transdermal drug delivery systems of a beta blocker: Design, in vitro, and in vivo characterization. Drug Delivery 2004;11(1):27–31.
   PubMed Web of Science ®Google Scholar
• Udhumansha U, Reddy MVS, Kumaresan R, Ahmad FJ, Khar RK. Transdermal therapeutic system of carvedilol; effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech 2007;8:E1–8.
   PubMed Web of Science ®Google Scholar
• Arora P, Mukherjee B. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci 2002;91(9):2076–2089.
   PubMed Web of Science ®Google Scholar
• Aqil M, Asgar A, Sultana Y, Najmi AK. Fabrication and evaluation of polymeric films for transdermal delivery of pinacidil. Pharmazie 2004;59:631–635.
   PubMed Web of Science ®Google Scholar
• Costa P, Lobo S. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13(2):123–133.
   PubMed Web of Science ®Google Scholar
• Singh B, Chauhan GS, Sharma DK, Kant A, Gupta I, Chauhan N. The release dynamics of model drugs from the psyllium and N-hydroxymethyacrylamide based hydrogels. Int J Pharmaceut 2006;325:15–25.
   PubMed Web of Science ®Google Scholar
• Kligman AM, Christopers E. Preparation of isolated sheets of stratum corneum. Arch Dermatol 1963;88:702–705.
   PubMed Web of Science ®Google Scholar
• Haigh JM, Smith EW. The selection and use of natural and synthetic membranes for in vitro diffusion experiments. Eur J Pharm Sci 1994;2:311–330.
   Web of Science ®Google Scholar
• Sonkro S, Purwo Y, Becket G, Rades T. Investigation of new born pig skin as an in vitro animal model for transdermal drug delivery. STP Pharma Sci 2003;13:33–139.
   Google Scholar
• Kakkar AP, Gupta A. Gelatin based transdermal therapeutic system. Indian Drugs 1992;29:308–312.
   Google Scholar
• Vaddi HK, Ho PC, Chan SY. Terpenes in propylene glycol as skin penetration enhancers: Permeation and partition of haloperidol, fourier transform infrared spectroscopy, and differential scanning calorimetry. J Pharm Sci 2002;91(7):1639–1651.
   PubMed Web of Science ®Google Scholar
• Ghosh MN. Fundamentals of experimental pharmacology. Kolkata: Hilton and Co.; 2005:190–197.
   Google Scholar
• Venishetty VK, Durairaj C, Sistla RK, Yamsani MK, Diwan PV. Development and validation of a reversed phase HPLC method for determination of nitrendipine in rat plasma: Application to pharmacokinetic studies. Biomed Chromatogr 2007;21:363–368
   PubMed Web of Science ®Google Scholar
• Dai S, McNeil JH. Fructose induced hypertension in rats is concentration and duration dependent. J Pharm Tox Methods 1999;33:101–107.
   Google Scholar
• Marinkovic V, Agbaba D, Vladimirov S, Stankovic S. Simultaneous HPLC determination of nitrendipine and impurities of the process of synthesis. J Pharm Biomed Anal 2001;24:993–998.
   PubMed Web of Science ®Google Scholar
• Aqil M, Ali A. Monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: in vitro characterization. Eur J Pharm Biopharm 2002;54:161–164.
   PubMed Web of Science ®Google Scholar
• SamuelovY, Donbrow M, Friedman M. Sustained release of drugs from ethgylcellulose-polyethylene glycol films and kinetics of drug release. J Pharm Sci 1979;68:325–329.
   PubMed Web of Science ®Google Scholar
• Ozyazici M, Gokce EH, Ertan G. Release and diffusional modeling of metronidazole lipid matrices. Eur J Pharm Biopharm 2006;63:331–339.
   PubMed Web of Science ®Google Scholar
• Roa PR, Rama KS, Diwan PV. Drug release kinetics from polymeric films containing propranolol hydrochloride for transdermal use. Pharm Dev Tech 2000;5:465–472.
   PubMed Web of Science ®Google Scholar
• Roa PR, Diwan PV. Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration. Drug Dev Ind Pharm 1998;24:327–336.
   PubMed Web of Science ®Google Scholar
• Draize JH, Woodward G, Calvery H. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membrane. J Pharmacol Exp Ther 1994;82:377–390.
   Google Scholar